368 related articles for article (PubMed ID: 28050923)
1. Incidence of Opportunistic Infections among HIV-Positive Adults on Highly Active Antiretroviral Therapy in a Teaching Hospital, India: Prospective Study.
Shenoy N; Ramapuram JT; Shenoy A; Ahmed J; Srikant N
J Int Assoc Provid AIDS Care; 2017; 16(3):309-311. PubMed ID: 28050923
[TBL] [Abstract][Full Text] [Related]
2. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
3. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy.
Schmidt-Westhausen AM; Priepke F; Bergmann FJ; Reichart PA
J Oral Pathol Med; 2000 Aug; 29(7):336-41. PubMed ID: 10947250
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of HIV associated oral lesions among adults in the era of HAART.
Mthethwa SR; Wanjau J; Chabikuli N
SADJ; 2013 Sep; 68(8):364-71. PubMed ID: 24660404
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of oral and systemic manifestations in pediatric HIV cohorts with and without drug therapy.
Jose R; Chandra S; Puttabuddi JH; Vellappally S; Al Khuraif AA; Halawany HS; Abraham NB; Jacob V; Hashim M
Curr HIV Res; 2013 Sep; 11(6):498-505. PubMed ID: 24329176
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of HIV-related oral manifestations and their association with HAART and CD4+ T cell count: a review.
Ottria L; Lauritano D; Oberti L; Candotto V; Cura F; Tagliabue A; Tettamanti L
J Biol Regul Homeost Agents; 2018; 32(2 Suppl. 1):51-59. PubMed ID: 29460518
[TBL] [Abstract][Full Text] [Related]
8. Highly-active antiretroviral therapy and oral opportunistic microorganisms in HIV-positive individuals of Thailand.
Arirachakaran P; Poovorawan Y; Dahlén G
J Investig Clin Dent; 2016 May; 7(2):158-67. PubMed ID: 25537925
[TBL] [Abstract][Full Text] [Related]
9. Oral lesions in Brazilian HIV-infected children undergoing HAART.
Miziara ID; Filho BC; Weber R
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
[TBL] [Abstract][Full Text] [Related]
10. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART.
Gaitán-Cepeda LA; Martínez-González M; Ceballos-Salobreña A
AIDS Patient Care STDS; 2005 Feb; 19(2):70-7. PubMed ID: 15716638
[TBL] [Abstract][Full Text] [Related]
11. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria.
Adurogbangba MI; Aderinokun GA; Odaibo GN; Olaleye OD; Lawoyin TO
Oral Dis; 2004 Nov; 10(6):319-26. PubMed ID: 15533205
[TBL] [Abstract][Full Text] [Related]
12. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
[TBL] [Abstract][Full Text] [Related]
13. HIV-related oral disease epidemiology among women: year 2000 update.
Shiboski CH
Oral Dis; 2002; 8 Suppl 2():44-8. PubMed ID: 12164659
[TBL] [Abstract][Full Text] [Related]
14. Orofacial lesions in 126 newly diagnosed HIV/AIDS patients seen at the University College Hospital, Ibadan.
Okoje VN; Obiechina AE; Aken'Ova YA
Afr J Med Med Sci; 2006 Mar; 35(1):97-101. PubMed ID: 17209335
[TBL] [Abstract][Full Text] [Related]
15. Oral manifestations of an HIV positive cohort in the era of highly active anti-retroviral therapy (HAART) in South London.
Eyeson JD; Tenant-Flowers M; Cooper DJ; Johnson NW; Warnakulasuriya KA
J Oral Pathol Med; 2002 Mar; 31(3):169-74. PubMed ID: 11903824
[TBL] [Abstract][Full Text] [Related]
16. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
[TBL] [Abstract][Full Text] [Related]
17. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
18. Oral manifestations in 70 German HIV-infected women.
Schmidt-Westhausen A; Grünewald T; Reichart PA; Pohle HD
Oral Dis; 1997 May; 3 Suppl 1():S28-30. PubMed ID: 9456652
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of oral manifestations of HIV infection in Rio De Janeiro, Brazil from 1988 to 2004.
Ferreira S; Noce C; Júnior AS; Gonçalves L; Torres S; Meeks V; Luiz R; Dias E
AIDS Patient Care STDS; 2007 Oct; 21(10):724-31. PubMed ID: 17949271
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of oral mucosal lesions in adults undergoing highly active antiretroviral therapy in Hong Kong.
Perera M; Tsang PC; Samaranayake L; Lee MP; Li P
J Investig Clin Dent; 2012 Aug; 3(3):208-14. PubMed ID: 22573355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
